Healthy adult volunteers or ones with a tendency for constipation
Conditions
Interventions
None listed
Sponsors
Ajinomoto General Foods, Inc.
Review team Mr. Kenji Yamamura, Technical Research &
Development. Ajinomoto General Foods, Inc. Ms. Kaho Kanatani, Technical Research &
Development, Ajinomoto General Foods, Inc. Research Collaborator Professor Hiroharu Kamioka, Faculty of Regional Environment Science, Tokyo University of Agriculture Dr. Takahiro Yoshizaki, Department of Nutritional Science, Department of Toyo University Ms. Mari Makishi, Toho University Narashino Media Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Systematic literature search using scientific databases and registered databases for clinical trials and systematic review will be performed. Key inclusion criteria are as follows: Participants: Healthy adults or adults with a tendency for constipation Intervention: Intake for more than 2 weeks Comparison: Placebo controll, in principle Outcome: Regulation of intestinal condition(see above outcome column) Study design: Adopt intervention study (Randomized parallel group comparison test, randomized cross over test, quasi-randomized parallel group comparison test, quasi-randomized cross over test, non-randomized parallel group comparison test)
Exclusion criteria
Exclusion criteria: We will exclude the literature which does not meet the key inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures are defecation days/week, defecation frequency/week, fecal Bifidobacterium count and the occupancy rate of Bifidobacterium in the total fecal microbiota. | — |
Secondary
| Measure | Time frame |
|---|---|
| Defecation amount per week is a secondary outcome. | — |
Countries
Japan
Contacts
Public ContactShigeyoshi Fujii
Ajinomoto General Foods, Inc. Technical Research and Development
Outcome results
None listed